Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats

Neuroscience

Volumn 204, Issue , 2012, Pages 64-73

  Newsom, R J ^a   Osterlund, C ^a   Masini, C V ^a   Day, H E ^a   Spencer, R L ^a   Campeau, S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

AM251; Endocannabinoid; HPA axis; Noise; Stress

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CORTICOSTERONE; CORTICOTROPIN; MESSENGER RNA;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY CORTEX; BASOLATERAL AMYGDALA; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE INDUCTION; HORMONE RELEASE; HYPOPHYSIS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMEDIATE EARLY GENE; LIMBIC CORTEX; MALE; MEDIAL GENICULATE BODY; MEDIAL PREOPTIC AREA; NERVE FIBER; NEUROMODULATION; NOISE MEASUREMENT; NOISE REDUCTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; STRIA TERMINALIS; THALAMUS VENTRAL NUCLEUS; WHITE NOISE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEURONS; NOISE; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; STRESS, PHYSIOLOGICAL;

EID: 84857126993     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.043     Document Type: Article

References (45)

1. Aso E., Ozaita A., Valdizán E.M., Ledent C., Pazos A., Maldonado R., Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem 2008, 105:565-572.
2. Atwood B.K., Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 2010, 160:467-479.
3. Briggs F., Usrey W.M. Emerging views of corticothalamic function. Curr Opin Neurobiol 2007, 18:403-407.
4. Burrow A., Day H.E., Campeau S. A detailed characterization of loud noise stress: intensity analysis of hypothalamo-pituitary-adrenal axis and brain activation. Brain Res 2005, 1062:63-73.
5. Campeau S., Akil H., Watson S.J. Lesions of the medial geniculate nuclei specifically block corticosterone release and induction of c-fos mRNA in the forebrain associated with adiogenic stress in rats. J Neurosci 1997, 17(15):5979-5992.
6. Campeau S., Watson S.J. Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J Neuroendocrinol 1997, 9(8):577-588.
7. Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal activity. J Neuroendocrinol Suppl 2008, 1:35-38.
8. Cota D., Steiner M.A., Marsicana G., Cervino C., Herman J.P., Grübler Y., Salla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148(4):1574-1581.
9. Day H.E., Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology 1996, 63(3):207-218.
10. Day H.E., Masini C.V., Campeau S. Reversible inactivation of the auditory thalamus disrupts HPA axis habituation to repeated loud noise stress exposures. Brain Res 2009, 1276:123-130.
11. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
12. Di S., Boudaba C., Popescu I.R., Weng F.J., Harris C., Marcheselli V.L., Bazan N.G., Tasker J.G. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 2005, 569:751-760.
13. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003, 23:4850-4857.
14. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005, 146:4292-4301.
15. Di S., Maxson M.M., Franco A., Tasker J.G. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J Neurosci 2009, 29:393-401.
16. Evanson N.K., Tasker J.G., Hill M.N., HIllard C.J., Herman J.P. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010, 151(10):4811-4819.
17. Finn D.P. Endocannabinoid-mediated modulation of stress responses: physiological and pathophysiological significance. Immunobiology 2010, 215(8):629-646.
18. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
19. Galiegue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Baouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232(1):54-61.
20. Ginsberg A.B., Pecoraro N.C., Warne J.P., Horneman H.F., Dallman M.F. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids. Stress 2010, 13:248-257.
21. Gorzalka B.B., Hill M.N. Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis. Curr Top Behav Neurosci 2009, 1:289-306.
22. Gorzalka B.B., Hill M.N., Hillard C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci Biobehav Rev 2008, 32:1152-1160.
23. Haller J., Varga B., Ledent C., Barna I., Freund T.F. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004, 19:1906-1912.
24. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991, 11:563-583.
25. Hill M.N., Carrier E.J., Ho W.S., Shi L., Patel S., Gorzalka B.B., Hillard C.J. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 2008, 18(2):221-226.
26. Hill M.N., McEwen B. Involvement of the endocannabinoid system in the neurobehavioral effects of stress and glucocorticoids. Prog Neuro-Psychopharmacol Biol Psychiatry 2010, 34:791-797.
27. Hill M.N., McLaughlin R.J., Morrish A.C., Viau V., Floresco S.B., Hillard C.J., Gorzalka B.B. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 2009, 34:2733-2745.
28. Hill M.N., McLaughlin R.J., Pan B., Fitzgerald M.L., Roberts C.J., Lee T.T., Karatsoreos I.N., Mackie K., Viau V., Pickel V.M., McEwen B.S., Liu Q.S., Gorlzalka B.B., Hillard C.J. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 2011, 31(29):10506-10515.
29. Hill M.N., Miller G.E., Carrier E.J., Gorzalka B.B., Hillard C.J. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009, 34:1257-1262.
30. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci 2010, 30(45):14980-14986.
31. Ho W.S., Patel S., Thompson J.R., Roberts C.J., Stuhr K.L., Hillard C.J. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. Br J Pharmacol 2010, 160(3):736-746.
32. Kovacs K.J. c-Fos as a transcriptional factor: a stressful (re)view from a functional map. Neurochem Int 1998, 33:287-297.
33. Lutz B. Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 2009, 9(1):46-52.
34. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145(12):5431-5438.
35. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signaling. Eur J Neurosci 2005, 21:1057-1069.
36. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
37. Rademacher D.J., Meier S.E., Shi L., Ho W.S., Jarrahian A., Hillard C.J. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 2008, 54:108-116.
38. Reibe C.J., Wotjak C.T. Endocannabinoids and stress. Stress 2011, 14(4):384-397.
39. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572.
40. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33:54-67.
41. Stella N., Piomelli D. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 2001, 425(3):189-196.
42. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995, 215:89-97.
43. Tasker J. Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 2004, 145(12):5429-5430.
44. Uriguen L., Pérez-Rial S., Ledent C., Palomo T., Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004, 46:966-973.
45. Valverde O. Participation of the cannabinoid system in the regulation of emotional-like behavior. Curr Pharm Des 2005, 11(26):3421-3429.